Where to Get Orforglipron (Foundayo): How to Get the GLP-1 Pill (2026)

Foundayo (orforglipron) is the first oral non-peptide GLP-1 receptor agonist, FDA-approved on April 1, 2026, and made by Eli Lilly.^[1] To get it, you need a prescription from a licensed provider — there is no over-the-counter version and no legal compounded or generic orforglipron, because the drug is brand-only and on-patent. The most direct route is LillyDirect, Lilly's own telehealth-and-pharmacy platform, which can connect you with a clinician and ship the medication; the standard alternative is a prescription from your own doctor filled at a retail pharmacy.^[2] With commercial insurance plus the manufacturer savings card, eligible patients pay as little as about $25 per month; self-pay runs roughly $149–$349 per month by dose tier through LillyDirect.^[2][3] This guide walks through every legitimate way to get Foundayo, who can prescribe it, what it costs with and without insurance, why "compounded orforglipron" is a red flag, and the cheaper alternative GLP-1 paths if brand orforglipron is out of reach. See our Foundayo drug page for the full clinical profile. This is general information, not medical advice — your prescriber individualizes your care.

Do you need a prescription for Foundayo?

Yes. Foundayo (orforglipron) is a prescription-only medication — you cannot buy it over the counter, and there is no legitimate way to obtain it without a prescription from a licensed provider.^[3] A clinician confirms that you meet the eligibility criteria for chronic weight management before writing the prescription. The prescription requirement is the same whether you go through LillyDirect's telehealth clinicians or through your own doctor; the only thing that changes is who writes it and where it is filled.

Because orforglipron is the active ingredient in a brand-only, on-patent product, there is exactly one legitimate form: brand-name Foundayo from Eli Lilly. There is no FDA-approved generic orforglipron and no compounded orforglipron — a point we return to below, because "compounded orforglipron" offers are a reliable sign of a scam or an unregulated grey-market product.

Who can prescribe orforglipron?

Any licensed provider with prescribing authority can prescribe Foundayo if they determine it is clinically appropriate — that includes your primary-care physician, an endocrinologist, an obesity-medicine specialist, a nurse practitioner, or a physician assistant. You do not need a specialist; many people get orforglipron from the same primary-care doctor who manages the rest of their care.

If you do not have a treating prescriber, or you would rather handle the whole process online, a telehealth clinician can evaluate you and write the prescription. LillyDirect partners with independent telehealth providers for exactly this reason, and a number of third-party telehealth platforms can also prescribe brand Foundayo and route it to a pharmacy. The clinician's job in every case is the same: confirm your eligibility for chronic weight management, review your medical history and current medications, and decide whether orforglipron is a safe and appropriate choice for you.

Route 1 — LillyDirect (the direct-to-consumer path)

LillyDirect (lillydirect.lilly.com) is Eli Lilly's own direct-to-patient platform — it combines a telehealth referral service with a pharmacy that dispenses and ships the medication.^[2] It is the most direct way to get Foundayo because it bundles the prescription and the fill into one workflow, and because the product comes straight through Lilly's own channel there is no question about authenticity. Here is how the route works step by step:

• Step 1 — Create an account and complete the intake. Go to lillydirect.lilly.com and start the weight-management flow. You answer a medical-history questionnaire covering your weight, BMI, any weight-related conditions, current medications, and contraindications.
• Step 2 — Connect with a provider (or use your own). If you do not already have a prescription, LillyDirect connects you with an independent telehealth clinician who reviews your intake and decides whether Foundayo is appropriate. If you already have a Foundayo prescription from your own doctor, you can have it sent to the LillyDirect pharmacy instead.
• Step 3 — Confirm eligibility and the prescription is issued. The clinician confirms you meet the chronic-weight-management criteria. There is no guarantee of a prescription — if Foundayo is not appropriate for you, the clinician will not write it.
• Step 4 — Choose insurance or self-pay and pay. You can run the prescription through your commercial insurance (with the savings card applied where eligible) or pay the self-pay price directly. LillyDirect shows your price before you check out.
• Step 5 — The pharmacy ships your medication. Foundayo is a once-daily tablet that does not require refrigeration, so it ships by standard mail with no cold-chain handling. Refills are managed through your account.

Route 2 — Your own doctor plus a retail pharmacy

The traditional route works just as well. Book an appointment with your primary-care provider or a weight-management specialist, discuss whether orforglipron is right for you, and — if they agree — have them send a prescription to your pharmacy of choice (CVS, Walgreens, Walmart, a local independent, or a mail-order pharmacy). You then pick it up or have it delivered like any other prescription.

This route is the natural choice if you already have a doctor who manages your weight or related conditions, if you want your full care coordinated in one place, or if you would rather use your existing pharmacy and insurance setup. You can still apply the manufacturer savings card at a retail pharmacy if you have eligible commercial insurance — the card is not exclusive to LillyDirect. The trade-off versus LillyDirect is simply that you coordinate the appointment and the fill yourself rather than having them bundled.

What Foundayo costs: insurance vs self-pay

Your out-of-pocket cost for Foundayo depends almost entirely on whether you have eligible commercial insurance and the manufacturer savings card, versus paying cash:

The self-pay price through LillyDirect is dose-tiered — roughly $149 to $349 per month depending on the strength you are prescribed — so your exact cash price depends on where you are in the titration schedule.^[2] For a deeper cost breakdown and how Foundayo compares with the cash-pay price of every other GLP-1, see our cheapest GLP-1 without insurance buyer's guide.

The savings card — and the Medicare/Medicaid exclusion

Eli Lilly offers a manufacturer savings card that can bring eligible commercial-insurance patients down to about $25 per month for Foundayo.^[2] As with every manufacturer copay card in this class, eligibility is limited to patients with commercial (private) insurance. If you are enrolled in Medicare, Medicaid, or any other federal or state government healthcare program, you are not eligible for the savings card — this is a hard exclusion required by federal anti-kickback rules, not a Lilly policy choice. Government-program beneficiaries pay whatever their plan's coverage and formulary allow, which varies widely. If you have Medicare or Medicaid, ask your plan whether Foundayo is on the formulary and what your copay would be, rather than counting on the card.

Why there is no compounded orforglipron (and the scam warning)

Orforglipron is a new, on-patent, brand-only medication. That means there is no FDA-approved generic orforglipron and — critically — no legal compounded orforglipron. Compounding pharmacies are generally only permitted to compound a copy of a commercially available drug under narrow circumstances, such as a documented drug shortage; orforglipron is a freshly launched patented product that is not in shortage, so broad commercial compounding of it is not permitted.

The practical takeaway is simple: if a website, clinic, or telehealth seller offers you "compounded orforglipron," treat it as a red flag. What you would actually be buying is an unregulated grey-market or research-chemical product with no FDA quality testing — no verified identity, purity, sterility, or dose accuracy — and likely a legal-liability shield ("for research use only") that does nothing to protect you. The only legitimate orforglipron is brand-name Foundayo from Eli Lilly, obtained with a prescription through LillyDirect, your doctor plus a pharmacy, or another licensed channel.

Eligibility: who can get Foundayo

Foundayo is approved for chronic weight management — that generally means adults with obesity, or adults who are overweight and also have a weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). A clinician confirms your eligibility based on your BMI, your weight-related conditions, your medical history, and a review of your current medications and any contraindications. There is no self-qualification: the prescriber makes the call, and if orforglipron is not appropriate for you, they will not prescribe it. To understand what to expect once you start, see our week-by-week Foundayo titration guide.

Cheaper alternative paths if brand Foundayo is out of reach

If you cannot get or afford brand Foundayo — for example you are uninsured, on Medicare or Medicaid without coverage, or simply want the lowest-cost GLP-1 option — there are legitimate alternatives. They are different molecules and (in two of the three cases) injectables, but they are the most affordable real GLP-1 routes:

• Compounded semaglutide or tirzepatide (injectable). Vetted telehealth providers offer compounded semaglutide or tirzepatide injections at roughly $99–$199/month — far below brand orforglipron. These are a different molecule and an injectable rather than a pill, and the regulatory status of broad commercial compounding is unsettled, so use a LegitScript-certified provider with a licensed dispensing pharmacy. This is the most affordable GLP-1 route for many people.
• Oral semaglutide (Rybelsus) by prescription. If you specifically want a pill, Rybelsus (oral semaglutide) is an FDA-approved oral GLP-1 you can get by prescription. It uses a different absorption mechanism than orforglipron and requires a fasting-window dosing protocol, but it is a legitimate brand alternative in tablet form.
• Brand injectable GLP-1s with their own savings programs. Wegovy and Zepbound have manufacturer cash-pay channels and savings cards of their own that may land cheaper than Foundayo for some patients, depending on dose and coverage.

To weigh a pill against an injection, see our comparison of oral GLP-1 pills vs the injectables, which covers how Foundayo, Rybelsus, and oral Wegovy stack up against the subcutaneous options on convenience, magnitude, and cost.

Want a clinician-led shortlist instead of the full table? Our editors' picks live on the best semaglutide providers page, with the scoring and verification behind each ranking.

Bottom line

• Foundayo (orforglipron) is the first oral non-peptide GLP-1 pill, FDA-approved April 1, 2026, from Eli Lilly — and it requires a prescription from a licensed provider.^[1][3]
• The most direct way to get it is LillyDirect (lillydirect.lilly.com), Lilly's own telehealth-plus-pharmacy platform; the standard alternative is your own doctor's prescription filled at a retail pharmacy.^[2]
• With eligible commercial insurance plus the savings card, Foundayo starts at about $25/month; self-pay via LillyDirect runs roughly $149–$349/month by dose tier.^[2]
• Medicare and Medicaid beneficiaries are not eligible for the savings card — they pay whatever their plan's formulary allows.
• There is no legal compounded or generic orforglipron — it is brand-only and on-patent. Any "compounded orforglipron" offer is a red flag.
• If brand Foundayo is out of reach, the cheapest legitimate GLP-1 routes are compounded semaglutide or tirzepatide injectables (~$99–$199/month from vetted telehealth) or oral semaglutide (Rybelsus) by prescription.

Frequently asked questions

Related research

• Foundayo drug page — the full clinical profile of orforglipron, including FDA status, mechanism, and dosing.
• How to take Foundayo: week-by-week titration guide — what to expect from the dose-escalation schedule once you start.
• Cheapest GLP-1 without insurance buyer's guide — Foundayo cash-pay pricing in context with every other legitimate GLP-1 channel.
• Oral GLP-1 pills vs injectables — how Foundayo, Rybelsus, and oral Wegovy compare with the subcutaneous options.
• Best semaglutide providers — our editors' vetted, scored shortlist of telehealth GLP-1 providers.

Pricing and verification. Foundayo savings-card "starting at about $25/month" (eligible commercial insurance) and self-pay "about $149–$349/month" reflect Eli Lilly / LillyDirect launch-period pricing and change over time — confirm the current price with LillyDirect or your pharmacy. The FDA approval (orforglipron, first oral non-peptide GLP-1 pill, April 1, 2026, Eli Lilly) is per the Eli Lilly press release. The prescription-only status, chronic-weight-management indication, and once-daily oral administration are per the FDA-approved FOUNDAYO Prescribing Information. PMID 38402332 (Ma X et al., orforglipron pharmacokinetics, Diabetes Ther 2024) was verified live via PubMed E-utilities esummary on 2026-06-13. Medicare and Medicaid beneficiaries are not eligible for the manufacturer savings card under federal anti-kickback rules.

Important disclaimer. This article is general educational information only — not medical advice, not legal advice, and not a substitute for consultation with a licensed prescriber. Whether Foundayo (orforglipron) is appropriate for you, and at what dose, is a decision only your prescriber can make. Where-to-get-it and pricing for prescription weight-management medication is a YMYL (Your Money or Your Life) topic; verify every regulatory, eligibility, and pricing claim with the manufacturer and your prescriber. Weight Loss Rankings does not prescribe, dispense, or endorse any specific compounding pharmacy or grey-market product, and there is no legitimate compounded or generic orforglipron.